The CPR, Pre-hospital ECPR and Early Reperfusion Study: A Target Trial Emulation
CHEER4TTE
1 other identifier
observational
250
1 country
1
Brief Summary
CHEER4TTE is a target trial emulation, designed to simulate a randomised controlled trial by utilising data from pre-existing data sources. The aim is to determine whether prehospital ECPR for refractory out-of-hospital cardiac arrest improves the rate of survival to hospital discharge when compared to conventional cardiac arrest care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
July 1, 2026
June 1, 2026
1.7 years
June 9, 2026
June 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival to hospital discharge
From meeting full eligibility criteria until the date/time of death or hospital discharge, assessed up to 180 days
Secondary Outcomes (5)
Low flow time
time from onset of arrest to time of ECPR flow, or time of death
ICU length of stay
From the date/time of ICU admission until the date/time of ICU discharge/death, assessed up to 180 days
Mechanical ventilation days
From date/time of mechanical ventilation commencement until date/time of liberation from mechanical ventilation assessed up to 180 days
ECMO complications
From the date/time of commencement of ECMO support until 1 week following the date/time of cessation of ECMO support
Rates of organ and tissue donation in non-survivors
In the 48hours following date/time of death
Study Arms (2)
Prehospital Extracorporeal Cardiopulmonary Resuscitation (ECPR) Strategy
Patients with refractory OHCA treated with scene-based, pre-hospital ECPR (Intervention) will be identified within two studies testing feasibility of prehospital ECPR for refractory OHCA in the metropolitan regions of Melbourne and Sydney. All intra-arrest and post-arrest care follow guidelines based on the Australian and New Zealand Council of Resuscitation recommendations supplemented by the Victorian ECMO Service (VECMOS) guidelines within Victoria and Agency for Clinical Innovation ECMO Clinical Practice Guidelines in NSW.
Conventional Cardiac Arrest Strategy
Patients with refractory OHCA treated with conventional cardiac arrest strategy (standard care) will be identified within NSW and Victorian Ambulance OHCA Registries. All intra-arrest and post-arrest care for patients in this group follow guidelines based on the Australian and New Zealand Council of Resuscitation recommendations.
Interventions
The Intervention being evaluated is the initiation of extracorporeal cardiopulmonary resuscitation (ECPR) at the scene, in addition to conventional cardiac arrest care.
Eligibility Criteria
Adult patients with refractory out-of-hospital cardiac arrest in the metropolitan regions of Sydney and Melbourne.
You may qualify if:
- Witnessed cardiac arrest
- Bystander CPR
- Refractory cardiac arrest (failure to achieve sustained ROSC \>20 minutes)
- Initial cardiac rhythm VF, VT or PEA
- Within the hours of prehospital ECPR service operation
You may not qualify if:
- Initial cardiac rhythm asystole
- ROSC with sustained recovery
- Unable to reach the patient and commence cannulation within 45 minutes of onset of arrest
- Evidence of/suspected end-stage disease:
- severe disability impairing activities of daily living
- end-stage organ disease - cardiac, liver, lung, renal
- other life-limiting diseases, e.g. malignancy, terminal illness
- advance health care directive
- Time periods of advanced public health restrictions in Victoria and NSW due to COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Monash University
Melbourne, Victoria, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2026
First Posted
July 1, 2026
Study Start
January 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 1, 2026
Record last verified: 2026-06